Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
Endocrine-Related Cancer|June 22, 2017
A MUTYH germline mutation is associated with small intestinal neuroendocrine tumorsJan P Dumanski, Chiara Rasi, Peyman Björklund, et al.
Plos One|November 8, 2017
Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinomaAbir Salwa Ali, Malin Grönberg, Birgitte Federspiel, et al.
Endocrine-Related Cancer|July 6, 2023
Germline pathogenic variants in patients with high-grade gastroenteropancreatic neuroendocrine neoplasmsAndreas Venizelos, Halfdan Sorbye, Hege Elvebakken, et al.
Oncotarget|August 11, 2016
TIMP-1 is under regulation of the EGF signaling axis and promotes an aggressive phenotype in KRAS-mutated colorectal cancer cells: a potential novel approach to the treatment of metastatic colorectal cancerLine S Tarpgaard, Maj Sofie Ørum-Madsen, Ib J Christensen, et al.
Journal of Neuroendocrinology|March 26, 2021
Surgery of the primary tumour in 201 patients with high-grade gastroenteropancreatic neuroendocrine and mixed neuroendocrine-non-neuroendocrine neoplasmsHans-Christian Pommergaard, Kirstine Nielsen, Halfdan Sorbye, et al.
Oncoimmunology|July 2, 2024
Complete response of metastatic microsatellite-stable BRAF V600E colorectal cancer to first-line oxaliplatin-based chemotherapy and immune checkpoint blockadeAnne Hansen Ree, Eirik Høye, Ying Esbensen, et al.
Neuroendocrinology|October 1, 2020
A Consensus-Developed Morphological Re-Evaluation of 196 High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Its Clinical CorrelationsHege Elvebakken, Aurel Perren, Jean-Yves Scoazec, et al.
British Journal of Cancer|February 23, 2026
Exploratory biomarkers for oxaliplatin-induced nivolumab responsiveness in metastatic microsatellite-stable colorectal cancerAnne Hansen Ree, Paula A Bousquet, Tina Visnovska, et al.
Endocrine-Related Cancer|December 13, 2018
Peptide receptor radionuclide therapy in gastroenteropancreatic NEN G3: a multicenter cohort studyEsben Andreas Carlsen, Nicola Fazio, Dan Granberg, et al.
Oncotarget|June 2, 2016
Survival-associated heterogeneity of marker-defined perivascular cells in colorectal cancerArtur Mezheyeuski, Maja Bradic Lindh, Tormod Kyrre Guren, et al.
Pageof 10